H36.81
Nonproliferative sickle-cell retinopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
Nonproliferative sickle-cell retinopathy is an eye condition that affects individuals with sickle cell disease. It involves changes in the blood vessels of the retina, which can impair vision if not monitored and managed properly. This form of retinopathy is distinguished by early signs of blood vessel damage before abnormal new vessel growth occurs. Recognizing and understanding this condition can help patients seek appropriate eye care and maintain eye health.
Causes & Symptoms
Clinical Causes: Genetic mutation causing abnormal hemoglobin in red blood cells Presence of sickle-shaped red blood cells that can block small blood vessels Chronic blood flow disruption in the retinal blood vessels Prolonged episodes of sickling leading to vascular damage within the eye
Key Symptoms: Often no early symptoms, making regular eye examinations important Progressive visual disturbances such as blurred vision Sudden vision loss in rare cases Floaters or spots in the visual field
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye exam performed by an ophthalmologist. Specific procedures include:
Treatment Protocols: While nonproliferative sickle-cell retinopathy may not always require immediate treatment, monitoring is essential. Possible management strategies include:
Clinical Advice & FAQs
Billing Guidance
Is H36.81 a billable ICD-10 code?
Yes, H36.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.81?
Clinical documentation must specify the nature of Nonproliferative sickle-cell retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference